Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Assets: 2024-2025

Historic Current Assets for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $620.7 million.

  • Kura Oncology's Current Assets rose 34.00% to $620.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $620.7 million, marking a year-over-year increase of 34.00%. This contributed to the annual value of $744.8 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Current Assets stood at $620.7 million for Q3 2025, which was down 5.97% from $660.1 million recorded in Q2 2025.
  • Kura Oncology's Current Assets' 5-year high stood at $744.8 million during Q4 2024, with a 5-year trough of $463.2 million in Q3 2024.